Navigation Links
Jazz Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results
Date:5/7/2009

$17,719 $11,341 Luvox CR 3,600 - Antizol and Antizol-Vet (1) - 2,643 ----- ----- Total $21,319 $13,984 ======= ======= (1) The Company sold its rights to and interests in Antizol and Antizol-Vet in August 2008. JAZZ PHARMACEUTICALS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) (Unaudited) March 31, December 31, 2009 2008 ---- ---- ASSETS Current assets: Cash and cash equivalents $17,015 $24,903 Restricted cash 775 1,913 Marketable securities - 1,004 Accounts receivable, net of allowances of $296 and $176 at March 31, 2009 and December 31, 2008, respectively 7,012 6,643 Inventories 4,430 4,788 Prepaid expenses 2,206 2,366 Other current assets 2,106 2,382 ----- ----- Total current assets 33,544 43,999 Property and equipment, net 2,140 2,514 Intangible assets, net 35,794 32,526 Goodwill
'/>"/>
SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
2. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
3. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
4. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
5. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
6. ACG Announces Major Gift by Salix Pharmaceuticals, Inc.
7. Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors
8. Elan Pharmaceuticals, Inc. Licenses Software and Databases From GeneGo
9. Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
10. Acura Pharmaceuticals, Inc. Announces Implementation of Reverse Stock Split and New Trading Symbol: ACPH
11. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...t 25 years, the number of Americans living with di...llion in 2009 to 44.1 million in 2034. Over the sa..., rising from $113 billion to $336 billion, even w...archers based at the University of Chicago report ...number of those with diabetes covered by Medicare ...
(Date:11/26/2009)...igger thrill when on an emotional rollercoaster, s...Day News) -- Call it the fear factor meets the jub...pectators -- especially those who root for the win...,s a closely contested match and victory was in do... , Chew on that this Thanksgiving weekend as yo...
(Date:11/26/2009)... Research Triangle Dental (RTDental),...Carolina, today announced the expansion of its ser... Dentist, Dr. Doug Macmillan. , ...Dental is pleased to announce that Dr. Doug Macmil...completed an additional advanced training seminar....
(Date:11/25/2009)...EDINA, Minn., Nov. 25 W...f their dentist. But a chiropractor can also give...emporal-Mandibular Joint, which is where your jaw ...oral bone). ,, The most common symptoms associ...licking or popping of the jaw. But many other sym...
(Date:11/25/2009)... TORONTO and CALGARY, Nov. 25 /PRNewswire/ - Senti...etic Resonance Imaging (MRI) coils and software an...oftware enabling technologies, have introduced a w...zation software. ,, This innovative interface i...medical imaging offering in the market. Calgary Sc...
Breaking Medicine News(10 mins):Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
... of Delphon Industries and industry leader in Elec...today the appointment of Diablo Sales & Market...pport in the western United States and Western Can...terials used in injection molding and extrusion fo...
...ion for Homecare supports expanded anti-fraud effo...ice (DOJ) and the Department of Health and Human S...Medicare. The two agencies outlined plans for expa...e stepped-up DOJ-HHS effort, the American Associat...
...dition , , WEDNESDAY, May 20 (HealthDay Ne...sk of autism, particularly in boys, has been ident...f 1,046 members of families with at least two sons...ported. , This variant of the gene, which helps mo...
...y says , , WEDNESDAY, May 20 (HealthDay Ne...hospital with the intense chest pain that doctors ...r artery-opening procedures within a few hours, a ...is often an issue about whether such assessment an...
... when even teens who have never tried a drop of al... and graduation are big events and there will be m...rtunities for alcohol to be served. , Assume tha...or the Advancement of Science (AAAS). So start tal...
...hildren,s Pediatric Disorders , , SANTA MONICA, C... world leader in orthopaedic patient care, researc...day the Renee and Meyer Luskin Children,s Clinic o...world-class pediatric orthopaedic care. Renee and ...
Other Medicine News:Health News:TouchMark Announces New Sales Representative 2Health News:American Association for Homecare Supports Expanded Federal Efforts by DOJ and HHS to Combat Medicare Fraud 2Health News:American Association for Homecare Supports Expanded Federal Efforts by DOJ and HHS to Combat Medicare Fraud 3Health News:American Association for Homecare Supports Expanded Federal Efforts by DOJ and HHS to Combat Medicare Fraud 4Health News:Gene Gives Clues to Why Autism More Common in Boys 2Health News:When Chest Pain Requires Quick Action in ER 2Health News:When Chest Pain Requires Quick Action in ER 3Health News:Use science to convince teens a sober prom is better, AAAS says 2Health News:World-Class Pediatric Orthopaedic Clinic Now Open for Kids 2
(Date:11/25/2009)... SAN DIEGO, Nov. 25 NuVa...any focused on developing products for minimally d...nced today that it will host a conference call on ...p.m. PT. The conference call will focus on curren...,s products and will include comments from managem...
(Date:11/25/2009)...EW YORK, Nov. 25 Reportlinker.com ...ilable in its catalogue: ,, Intranasal Drug De...www.reportlinker.com/p0164267/Intranasal-Drug-Deli...US intranasal drug delivery market is witnessing a...elivery of conventional local therapeutic drugs to...
(Date:11/25/2009)... VIEW, Calif., Nov. 25 ChemoCent...cal data from the Company,s PROTECT-1 (the Prospec... disease Trial) of Traficet-EN(TM) (CCX282-B) in p...monstrated clinical efficacy with a favorable safe...ed evidence of clinical efficacy in the reduction ...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3NuVasive Announces Conference Call and Webcast Regarding Reimbursement 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Dense Breasts Raise Risk of Cancer Recurrence 60997 1Dense Breasts Raise Risk of Cancer Recurrence 60997 2Dense Breasts Raise Risk of Cancer Recurrence 60997 3Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 60994 1Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 60994 2Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 60994 3American Academy of Physician Assistants Applauds U S House of Representatives for Passing Health Care Reform Bill 60989 1American Academy of Physician Assistants Applauds U S House of Representatives for Passing Health Care Reform Bill 60989 2
... 09, 2007 /PRNewswire-FirstCall/ --,Telik, Inc. an...enter Phase 2 trial of the triplet combination of ... and paclitaxel will be,presented at the 98th annu...Research (AACR) in Los Angeles. Preclinical studie...tic cancer cell growth,inhibition with TELCYTA in ...
...SS WIRE)--Apr 11, 2007 - New data,supporting the c...,the most advanced investigational oral protease i...HCV) infection, will be presented,at the 42nd Annu...dy of the Liver (EASL) in Barcelona this week. In ...een accepted for presentation,at the EASL conferen...
Other Medicine Technology:Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 2Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 3Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 2Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 3Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 4Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 5Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 6
ACE SCFE Screw
4.0 mm and 6.5 mm Cannulated Screws
...bles fixation of humeral shaft fractures while avo...associated with antegrade nailing. , ,In addition,...ng using a nail-mounted targeting device. This dev...th the patient in the prone position. In cases tha...
...edical technology company and a key participant in...es a new generation Automated Coagulation Timer. T...electromechanical coagulation instrument designed ... citrated whole blood, and plasma samples. Clottin...
Medicine Products: